Compound repurposing
Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.
Show/Hide Filters
Hormaomycin (HB3932)
Description:Selective peptide lactone antibacterial agent. Antibiotic.
Purity:>98%
Hypericin (HB3934)
Description:Photosensitive compound. Shows anticancer, antiviral and antidepressant action.
- Description:
Water soluble Toll-like receptor 7 (TLR7) agonist. Stimulates cytokine production.
Purity:>98%